Copyright
©The Author(s) 2020.
World J Hepatol. Sep 27, 2020; 12(9): 661-671
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.661
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.661
Table 3 Differentiation of nonalcoholic steatohepatitis from isolated steatosis using different contrast enhancement index cut-offs
| CEI cut-off | Sensitivity (%) | Specificity (%) |
| 1.66 | 32 | 94 |
| 1.76 | 47 | 83 |
| 2.00 | 92 | 28 |
- Citation: Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez RM, Rodrigues RS. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol 2020; 12(9): 661-671
- URL: https://www.wjgnet.com/1948-5182/full/v12/i9/661.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i9.661